These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 1992188

  • 41. EMEA approves OGS drug rejected by FDA.
    Mitchell P.
    Nat Biotechnol; 2002 Sep; 20(9):858-9. PubMed ID: 12205490
    [No Abstract] [Full Text] [Related]

  • 42. HHS defends expanded 340B drug discounts.
    Lee J.
    Mod Healthc; 2014 Jun 16; 44(24):9. PubMed ID: 25137989
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Review of regulatory recommendations for orphan drug submissions in the Netherlands and Scotland: focus on the underlying pharmacoeconomic evaluations.
    Vegter S, Rozenbaum MH, Postema R, Tolley K, Postma MJ.
    Clin Ther; 2010 Aug 16; 32(9):1651-61. PubMed ID: 20974323
    [Abstract] [Full Text] [Related]

  • 47. Removal of the EMA orphan designation upon request of the sponsor: cui prodest?
    Montanaro N, Bonaldo G, Motola D.
    Eur J Clin Pharmacol; 2021 Jul 16; 77(7):1057-1063. PubMed ID: 33501508
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Regulators adopt more orphan drugs.
    Reardon S.
    Nature; 2014 Apr 03; 508(7494):16-7. PubMed ID: 24695293
    [No Abstract] [Full Text] [Related]

  • 52. Orphan Drug Designation and Exclusivity for "Same Drugs".
    Hong P, Sarpatwari A, Kesselheim AS.
    J Law Med Ethics; 2019 Jun 03; 47(2):347-349. PubMed ID: 31298092
    [No Abstract] [Full Text] [Related]

  • 53. Current status of orphan disease drug development.
    Thoene JG.
    Curr Opin Pediatr; 1994 Apr 03; 6(2):209-12. PubMed ID: 8032402
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Repairing the broken market for antibiotic innovation.
    Outterson K, Powers JH, Daniel GW, McClellan MB.
    Health Aff (Millwood); 2015 Feb 03; 34(2):277-85. PubMed ID: 25646108
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Development of an orphan drug by a start-up company. MetroGel for rosacea.
    Borgman RJ.
    Int J Technol Assess Health Care; 1992 Feb 03; 8(4):566-72. PubMed ID: 1464478
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.